Clinical Trials
6 trialsNCT06058377 2026-06-05
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT04638725 2026-06-04
SIGHER
Centre Paul Strauss
Recruiting
NCT06632977 2026-06-02
PREDICT
Alliance for Clinical Trials in Oncology
Phase 2 Recruiting
NCT07091617 2026-06-02
Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT05676099 2026-05-29
TSC Biosample Repository and Natural History Database
National Tuberous Sclerosis Association
Recruiting
NCT05649072 2026-05-22
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
M.D. Anderson Cancer Center
Phase NA Recruiting